The star expert witness in Oklahoma’s $10 billion opioid crisis trial against Johnson & Johnson gave damning testimony Tuesday that he was attacked by doctors with financial interests in opioid drugmakers when he spoke out against heavily prescribing the drugs.
Read moreInsys Therapeutics filed for Chapter 11 bankruptcy on Monday, due to numerous lawsuits challenging its acts in the nationwide opioid epidemic, and a $225 million fraud settlement with the federal government.
Read moreBetween 1999 and 2017, nearly 400,000 people in the United States died from overdoses involving opioids and by 2017, over 2 million people had been diagnosed with an opioid use disorder. Legal aid may be the key to facilitating recovery for them.
Read moreAn Ohio doctor was charged with murder Wednesday in the deaths of 25 hospital patients who authorities say were killed with deliberate overdoses of painkillers, many of them administered by other medical workers on his orders.
Read moreOpioid manufacturer Insys Therapeutics agreed to pay $225 million to settle a U.S federal government probe of the company’s marketing and kickback scheme involving the distribution of a sublingual opioid spray, prosecutors said Wednesday.
Read moreOklahoma’s bellwether trial over the opioid crisis began Tuesday with officials accusing pharmaceutical giant Johnson & Johnson of acting as a “drug kingpin” that killed over 4,600 Oklahomans through unintentional overdoses and created a public nuisance that cost the state billions of dollars.
Read moreIowa and four other states have joined a growing number of lawsuits against drugmaker Purdue Pharma for its role in creating and profiting from a nationwide wave of opioid addictions, taking aim at a member of the billionaire Sackler family that is behind one of the largest opioid-producing companies in the country.
Read moreA pharmaceutical company founder accused of paying doctors millions in bribes to prescribe a highly addictive fentanyl spray was convicted Thursday in a case that exposed such marketing tactics as using a stripper-turned-sales-rep to give a physician a lap dance.
Read moreThe Washington Post argued before a Sixth Circuit panel Thursday for the release of drug distribution data provided by the federal government in a multidistrict litigation against the manufacturers, distributors and retailers of prescription opioid medications.
Read moreOpening a new front in the war on opioids, the Department of Justice brought charges Tuesday that could carry 10-year minimum sentences for two executives of the Rochester Drug Co-operative.
Read moreAmid an ongoing public health crisis, the Census Bureau has found that grandparents are raising children more often in states with higher opioid prescription rates, particularly in the South.
Read moreFederal authorities said Wednesday they have charged 60 people, including a doctor accused of trading drugs for sex and another of prescribing to his Facebook friends, for their roles in illegally prescribing and distributing millions of pills containing opioids and other drugs.
Read moreSettling claims that some of its Rhode Island stores filled invalid prescriptions, CVS Pharmacy reached a $535,000 settlement Tuesday with federal prosecutors.
Read moreIn a surprise move, frustrated Oklahoma officials dropped all claims except for a public nuisance claim against opioid manufacturers Thursday in order to end what they say are stall tactics before the bellwether case goes to trial next month.
Read moreInsys Therapeutics and its former vice president of sales Alec Burlakoff will pay $9.5 million to settle claims that they paid doctors lucrative “speaker fees” in exchange for the doctors writing prescriptions for Insys’ flagship drug, Subsys, “a fentanyl drug,” the Arizona attorney general said.
Read more
(CN) – A New York District judge granted pharmaceutical company Alkermes PLC’s motion to dismiss a shareholder class action alleging the company misrepresented sales figures and comparative effectiveness for a drug developed to treat opioid dependence.
Read moreAmid the state’s nine opioid deaths a day, New York Thursday sued in federal court the billionaire family that controls one of the largest opioid-producing companies in the country, becoming the third state to do so.
Read moreThe maker of prescription painkiller OxyContin and the wealthy family that owns the company agreed Tuesday to pay $270 million to settle claims by the state of Oklahoma as authorities struggle to respond to the nationwide opioid addiction epidemic.
Read moreWhile drug epidemics in the United States tend to affect non-whites, the opioid crisis in America has targeted largely low-income white populations, according to a new study released Monday by the American Medical Association.
Read more